Custom gene and vector synthesis - integrated DNA technologies INC:1107504 [17-004550]
Ended Awarded Last action
- Contract number
- HHSN26400005
- Awardee
-
Integrated DNA Technologies, Inc. UEI P55FTN1UMYZ1 Part of Danaher Corporation
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,597
Award facts
- Contract value 100% obligated
- $19,597.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Coralville, IA 52241, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Funding Only Action | -$36 | |
| Original award | $19,633 |
About this award
Integrated DNA Technologies, Inc. (IDT) was awarded a $19,597.35 firm fixed-price Blanket Purchase Agreement (BPA) call contract on July 26, 2017, for custom gene and vector synthesis services. The contract is designated as a Total Small Business set-aside and was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health. Performance of the work is scheduled to occur in Coralville, Iowa, with an ultimate completion date of April 13, 2022. IDT, a specialized manufacturer of nucleic acid products and molecular biology supplies, serves as the prime contractor on this engagement.
This award reflects NIAMS's procurement of custom DNA and gene synthesis capabilities to support the institute's biomedical research mission in arthritis, musculoskeletal diseases, and skin conditions. IDT's expertise in custom oligonucleotide and gene fragment synthesis aligns with NIAMS's research needs across its portfolio of investigator-initiated and institute-funded research programs. As the parent company of IDT, Danaher Corporation provides additional technological infrastructure and resources through its diverse portfolio of scientific and diagnostics subsidiaries, positioning the awarded entity to deliver high-quality molecular biology reagents to federal research initiatives.
Quick answers
Who was awarded contract HHSN26400005?
HHSN26400005 was awarded to Integrated DNA Technologies, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on July 26, 2017.
How much is contract HHSN26400005 worth?
The government has obligated $19,597 on HHSN26400005.
Is contract HHSN26400005 an order under another contract?
Yes. HHSN26400005 is a BPA call under HHSN263201500214B, a blanket purchase agreement.
Was contract HHSN26400005 competed?
The extent of competition for HHSN26400005 was competed under sap. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award